#medication-safety
FDA classifies levothyroxine recall over subpotency
The FDA has classified a nationwide levothyroxine recall involving select Major Pharmaceuticals tablets after potency testing found some lots contained less active ingredient than required. The action covers multiple strengths and package sizes used for thyroid treatment. Nationwide levothyroxine recall The U.S. Food and Drug Administration has classified a nationwide recall involving select lo
FDA classifies levothyroxine recall over subpotency
The FDA has classified a nationwide levothyroxine recall involving select Major Pharmaceuticals tablets after potency testing found some lots contained less active ingredient than required. The action covers multiple strengths and package sizes used for thyroid treatment. Nationwide levothyroxine recall The U.S. Food and Drug Administration has classified a nationwide recall involving select lo
Nationwide Cetirizine Recall Covers Four Lots Over Ranitidine Risk
A nationwide cetirizine recall covers four lots of 5 mg allergy tablets distributed by Rising Pharma after red dots and discoloration suggested possible ranitidine contamination. Consumers should check lot numbers, watch for severe allergic reactions and report problems. Unique Pharmaceutical Laboratories has voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg at the consumer level because of potent
Nationwide Cetirizine Recall Covers Four Lots Over Ranitidine Risk
A nationwide cetirizine recall covers four lots of 5 mg allergy tablets distributed by Rising Pharma after red dots and discoloration suggested possible ranitidine contamination. Consumers should check lot numbers, watch for severe allergic reactions and report problems. Unique Pharmaceutical Laboratories has voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg at the consumer level because of potent









